There is intense interest in how employment-based health plans are responding to all the effects of reform implementation, even though the employer mandate has not officially kicked-in. The Corporate Executive Board and HighRoads collaborated on a survey to compare features of 2014 plans with those in 2013 (HighRoads Paper) The focus of the report is on cost-sharing features. In 2014, according to this survey, plans with high deductibles grew by 2% to 25% of all plans, but interestingly, the number with a zero deductible rose more, by 9%, to 29%. Plans have been moving from copays to coinsurance for office visits; 42% will use coinsurance in 2014, compared to 35% in 2013. Out-of-pocket maximums are also rising, 66% of 2014 plans have maximums over $2500, while only 58% did in 2013. Emergency room copays have risen, to an average of $113 in 2014, but the rise has been relatively slow over the last few years, just slightly above inflation. Similarly, office visit copays for in-network providers have leveled off in the $20 to $22 range. The spread between these in-network office visit copays and urgent care copays, which are around $33, has also stayed stable. It is unclear whether the spread needs to be larger to create an incentive to avoid urgent care use, but perhaps plan sponsors aren’t seeing negative effects from urgent care use. Mental health service copays have become equivalent to physical condition copays, as required by the mental health parity law. The reform law required that services defined as preventive be provided without a copay and without being subject to the deductible. A number of plans, around 28%, are providing preventive coverage without cost-sharing even for out-of-network providers. Drug copays for both generics and brand-name prescriptions are pretty flat, at $9 for generics and $26 for brand-names in 2014. The overall picture is that cost-sharing is continuing to rise in most plans, including most importantly, the out-of-pocket maximums.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
More money pouring into young health care companies as Dispatch Health gains $330 million in new capital to deliver high acuity health care in a patient’s home, rather than a...
November 30, 2022
A lot of money is invested in health care startups and growth companies, since health care is 20% of the economy, but the returns aren’t always good. Here is another...
November 1, 2022
HealthJoy delights investors by garnering $60 million in mindless new capital to support its benefits navigation tool. Another sign of too much capital still floating around out there.
November 1, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace